Surface glycoprotein
[대역어] 표면당 단백질
[용어속성] Term
[용어속성] Term
How Do Enveloped Viruses Exploit the Secretory Proprotein Convertases to Regulate Infectivity and Spread?
Review
[키워드] Activation
Antiviral
arenavirus
binding
block viral entry
cleavage
contributed
convertase
COVID-19
Dengue
domain
enveloped virus
Fever
function
furin
glycoprotein
Hemorrhagic
Host
host cell
implicated
Infection
Infectivity
inhibition
limit
mechanism
membrane
membrane-bound
Other
pandemic
Pandemics
PC1
PC2
PCSK9
plasma membranes
Proprotein
proprotein convertases
Proteins
Regulation
responsible
S-protein
SARS-CoV-2
secretory
serine protease
SKI-1/S1P
Surface glycoprotein
tested
tissues
to define
Vaccine
viral envelope
viral infection
viral infections
viral surface
virus
viruses
[DOI] 10.3390/v13071229 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/v13071229 PMC 바로가기 [Article Type] Review
Long‐lived macrophage reprogramming drives spike protein‐mediated inflammasome activation in COVID‐19
Article
[키워드] adaptive
cause
convalescent
COVID‐19
COVID‐19 patient
COVID‐19 patients
Epigenetic
gene expression signature
healthy
hyperinflammation
Hyperinflammatory syndrome
Immunity
immunology
in vivo
Inflammasome
inflammasome activation
Innate
innate immune
innate immune memory
Innate immunity
longitudinal analysis
Macrophage
Microbiology, Virology & Host Pathogen Interaction
Modification
monocyte
naïve individuals
NLRP3
patients
responsible
resulting
robust
SARS‐CoV‐2
SARS‐CoV‐2 infection
SARS‐CoV‐2
secretion
Signaling
Spike protein
subset
Surface glycoprotein
transcriptional
Trigger
vaccine antigen
viral control
[DOI] 10.15252/emmm.202114150 PMC 바로가기 [Article Type] Article
[DOI] 10.15252/emmm.202114150 PMC 바로가기 [Article Type] Article
SARS-CoV-2 vaccines: a triumph of science and collaboration
SARS-CoV-2 백신: 과학과 협력의 승리
Review
[키워드] altruism
clinical trial
clinical trials
COVID-19
demonstrated
distribution
Effectiveness
Efficacy
Emergency use
evade
Evidence
harmonization
Immunity
less
mRNA
mRNA vaccine
open
overcome
Phase III clinical trials
protein subunit vaccine
reduction in
risk
S-protein
safety profile
SARS-CoV-2
SARS-CoV-2 vaccine
SARS-CoV-2 variant
SARS-CoV-2 variants
Sequencing
severe COVID-19
Side effect
Study participants
Subunit vaccine
Surface glycoprotein
symptomatic
symptomatic COVID-19
vaccination against COVID-19
Vaccine
Vaccines
Viral
Viral vector
[DOI] 10.1172/jci.insight.149187 PMC 바로가기 [Article Type] Review
[DOI] 10.1172/jci.insight.149187 PMC 바로가기 [Article Type] Review
Host barriers to SARS-CoV-2 demonstrated by ferrets in a high-exposure domestic setting
높은 노출 국내 환경에서 흰 족제비에 의해 입증 된 SARS-CoV-2에 대한 호스트 장벽
423
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Angiotensin-converting enzyme
Antibody assays
barrier
circulating
cleavage
Contact
coronavirus
COVID-19
decrease
demonstrated
direct contact
discrepancy
Effect
Efficiency
environmental exposure
Evidence
evidence of
experiment
exposure to
Factor
ferret
ferrets
furin
Genetic
genetic factors
genetics
Host
host adaptation
hosts
Human
hypothese
idea
Infection
Laboratory
limit
Mutation
natural experiment
natural infection
no evidence of
onward transmission
positive
predicted
provide
raising
respiratory
respiratory virus
respiratory viruses
risk
S1/S2 cleavage site
SARS-CoV-2
SARS-CoV-2 disease
SARS-COV-2 infection
SARS-CoV-2 sequence
SARS-CoV-2 sequences
SARS-CoV-2 susceptibility
SARS-CoV-2 transmission
second
sequence
severe acute respiratory syndrome Coronavirus
shown
Significance
spike
Support
Surface glycoprotein
susceptible
symptomatic
symptomatic COVID-19
symptomatic disease
These data
Transmission
Viral
viral adaptation
Virology
virus
viruses
while
[DOI] 10.1073/pnas.2025601118 PMC 바로가기 [Article Type] 423
[DOI] 10.1073/pnas.2025601118 PMC 바로가기 [Article Type] 423
50 Years of structural immunology
JBC Reviews
[키워드] adaptive
antibodies
antibody
Antigen
antigens
build
CDR, complementarity-determining region
cellular
cellular immunity
CoV, coronavirus
cytokine
engage
EPO, erythropoietin
EPOR, erythropoietin receptor
equivalent
example
explained
germline gene
GP, glycoprotein
HA, hemagglutinin
hGH, human growth hormone
host cell
Humoral immunity
Ig, immunoglobulin
immune recognition
immune response
immune system
Immunity
immunological
immunology
include
Inflammation
information
inherent
innate immune system
lipids
MHC
MHC molecule
MHC, major histocompatibility complex
microbial
microbial pathogens
momentum
MR, molecular replacement
Mutation
NA, neuraminidase
NKT cell, natural killer T cell
NTD, N-terminal domain
nucleic acids
pathogen
PDB, Protein Data Bank
peptide
processed
Protein
protein antigen
Proteins
RBD, receptor-binding domain
receptor
receptors
recognize
Recombination
regulate
RSV, respiratory syncytial virus
SARS-CoV-2
Small molecules
specificity
Structure
Surface glycoprotein
T cell receptors
T cells
target
TCR, T cell receptor
the antibody response
TLR
TLR, Toll-like receptor
Vaccine
viral antigens
virus
VLR
VLR, variable lymphocyte receptor
[DOI] 10.1016/j.jbc.2021.100745 PMC 바로가기 [Article Type] JBC Reviews
[DOI] 10.1016/j.jbc.2021.100745 PMC 바로가기 [Article Type] JBC Reviews
Neutralizing antibodies targeting the SARS-CoV-2 receptor binding domain isolated from a naïve human antibody library
순수 인간 항체 라이브러리에서 분리된 SARS-CoV-2 수용체 결합 도메인을 표적으로 하는 중화 항체
Article
[키워드] ACE2
Analysis
angiotensin-converting enzyme 2
antibody
binding
block
COVID-19
COVID-19 infection
elicit
elicited
epitope
highlight
humoral
in vitro
in vivo
inhibit
Interaction
lentivirus
majority
Mutation
naïve
neutralized
Neutralizing
neutralizing antibody
overlapping
patients
RBD
receptor
Receptor binding domain
robust antibody response
SARS-CoV-2
SARS-CoV-2 neutralizing antibodies
Surface glycoprotein
the RBD
the SARS-CoV-2
viral infection
yeast
yeast surface display.
yielding
[DOI] 10.1002/pro.4044 PMC 바로가기 [Article Type] Article
[DOI] 10.1002/pro.4044 PMC 바로가기 [Article Type] Article
Immunoinformatic approach to design a multiepitope vaccine targeting non-mutational hotspot regions of structural and non-structural proteins of the SARS CoV2
Bioinformatics
[키워드] 3D structure
Analysis
Antigen
antigen processing
antigenicity
approach
B cell
binding affinity
binding energy
calculated
caused
Cell
complex
coronavirus 2
cross-reactivity
database
demonstrated
docking
envelope protein
epitope
Epitopes
evaluated
Extracellular
high mortality
HLA
host cell
hotspot
IFN
immune response
Immune simulation
induce
Infection
injection
interacting residue
Interaction
leukocyte
linker
MDs
Membrane proteins
memory
Microbiome
Molecular dynamics simulation
morbidity
multiepitope vaccine
Mutation
mutations
non-structural protein
ORF1ab polyprotein
ORF3a protein
ORF8 protein
outbreak
pandemic
Physicochemical properties
predicted
Protein
proteomics
Region
respiratory
Result
SARS CoV2
screened
selected
sensitivity
Seven
similarity
strong immune response
Study design
Surface glycoprotein
T cell
the vaccine
TLR
TLRs
Toll-like receptor
Toxicity
vaccination
Vaccine
vaccine construct
virus
was performed
[DOI] 10.7717/peerj.11126 PMC 바로가기 [Article Type] Bioinformatics
[DOI] 10.7717/peerj.11126 PMC 바로가기 [Article Type] Bioinformatics
A cross-neutralizing antibody between HIV-1 and influenza virus
Research Article
[키워드] Analysis
antibodies
antibody
Antigen
antigenic evolution
approaches
Cluster
compose
Comprehensive
conserved
cross-neutralizing
envelope
envelope protein
epitope
Evolution
glycan
glycans
glycosylated
glycosylation site
H3N2
H3N2 strain
HIV-1
immune response
immunogenic
influenza hemagglutinin
Influenza virus
Isolation
N -glycosylation
negative-stain electron microscopy
neutralize
neutralizing antibody
pandemic
Patient
persistence
Protein
provided
RBS
receptor binding site
required
Seasonal influenza
Spread
Strains
sugars
Surface glycoprotein
survival
target
Vaccines
viral pathogens
viral surface
virus
viruses
[DOI] 10.1371/journal.ppat.1009407 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.ppat.1009407 PMC 바로가기 [Article Type] Research Article
An Overview of Spike Surface Glycoprotein in Severe Acute Respiratory Syndrome–Coronavirus
Molecular Biosciences
[키워드] antiviral drug
binding
China
cleaved
contagious
Corona
coronavirus
CoV
COVID-19
disease
drug design
ENCODE
entry inhibitors
envelope protein
enzyme
Genetic
Genome
highest
Host
host cell
host cell receptor
include
inhibit
inhibitor
initial
involved
membrane protein
MERS
monomer
mortality rate
non-structural protein
non-structural proteins
Novel coronavirus
nucleocapsid protein
predominant
protease
researcher
respiratory
S1 and S2
S1 domain
S1/S2
S2 domain
SARS-CoV-2
shown
small molecule
spike
spike (S) glycoprotein
structural protein
structural proteins
subunit
surface
Surface glycoprotein
target
the S protein
the WHO
therapeutic
treat
Treatment
Vaccine
viral genome
viral infection
viral infections
virulent
virus
[DOI] 10.3389/fmolb.2021.637550 PMC 바로가기 [Article Type] Molecular Biosciences
[DOI] 10.3389/fmolb.2021.637550 PMC 바로가기 [Article Type] Molecular Biosciences